Literature DB >> 12606693

Melatonin nocturnal surge modulates nicotinic receptors and nicotine-induced [3H]glutamate release in rat cerebellum slices.

Regina P Markus1, Jussara M Santos, Wagner Zago, Livia A C Reno.   

Abstract

In mammals, the most important synchronizer for endogenous rhythms is the environmental light/dark cycle. In this report we have explored the ability of light/dark cycle and melatonin, the pineal hormone released during the night, to modulate cerebellar cholinergic input by interfering with the nicotinic acetylcholine receptors' (nAChRs) availability. Through the analysis of the response to selective cholinergic agonists and antagonists, we observed that nAChRs containing the alpha7 gene product mediate the release of [(3)H]glutamate from rat cerebellum slices. The [(3)H]glutamate overflow induced by alpha7 nAChR activation was higher during the dark phase, although the number of alpha-[(125)I]bungarotoxin binding sites, but not the [(3)H]nicotine binding sites (B(max)), was reduced. On the other hand, glutamate-evoked [(3)H]glutamate release was not modified by the hour of the day. Finally, we show that the nocturnal increase in nicotine-evoked [(3)H]glutamate release is imposed by a nocturnal surge of melatonin, as it is abolished when pineal melatonin production is inhibited by either maintaining the animals in constant light for 48 h or by injecting propranolol just before lights off for 2 days. The difference between light and dark [(3)H]glutamate-evoked release is restored in propranolol-treated animals that received melatonin during the dark period. In conclusion, we show that nicotine-evoked [(3)H]glutamate release in rat cerebellum presents a diurnal variation, driven by nocturnal pineal melatonin surge.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606693     DOI: 10.1124/jpet.102.045625

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

Review 1.  Neuronal activity: from in vitro preparation to behaving animals.

Authors:  François Windels
Journal:  Mol Neurobiol       Date:  2006-08       Impact factor: 5.590

2.  Diurnal variation in nicotine sensitivity in mice: role of genetic background and melatonin.

Authors:  Sharon Mexal; William J Horton; Eric L Crouch; Sheila I B Maier; Andra L Wilkinson; Marisa Marsolek; Jerry A Stitzel
Journal:  Neuropharmacology       Date:  2012-07-20       Impact factor: 5.250

3.  Melatonin administration alters nicotine preference consumption via signaling through high-affinity melatonin receptors.

Authors:  William J Horton; Hannah J Gissel; Jennifer E Saboy; Kenneth P Wright; Jerry A Stitzel
Journal:  Psychopharmacology (Berl)       Date:  2015-02-24       Impact factor: 4.530

4.  Modulation of α7nAchR by Melatonin Alleviates Ischemia and Reperfusion-Compromised Integrity of Blood-Brain Barrier Through Inhibiting HMGB1-Mediated Microglia Activation and CRTC1-Mediated Neuronal Loss.

Authors:  Shuang Chen; Yanyun Sun; Fei Li; Xinyu Zhang; Xiaoyan Hu; Xiaoyun Zhao; Yixuan Li; Hui Li; Jianliang Zhang; Wenlan Liu; Guo-Qing Zheng; Xinchun Jin
Journal:  Cell Mol Neurobiol       Date:  2021-07-01       Impact factor: 4.231

5.  The cellular state determines the effect of melatonin on the survival of mixed cerebellar cell culture.

Authors:  Daiane Gil Franco; Regina P Markus
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

Review 6.  Melatonin in drug addiction and addiction management: Exploring an evolving multidimensional relationship.

Authors:  Olakunle J Onaolapo; Adejoke Y Onaolapo
Journal:  World J Psychiatry       Date:  2018-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.